Anatara Lifesciences Ltd

ASX:ANR ISIN:AU000000ANR0

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit www.anataralifesciences.com.

     

News

Anatara Lifesciences Ltd (ASX:ANR) Chairman's Address to Shareholders and Presentation

🕔11/26/2020 10:51:01 AM 710

The last twelve months have seen exciting developments as Anatara Lifesciences Ltd (ASX:ANR) advances our lead human health product, our Gastrointestinal ReProgramming (GaRP) complementary medicine.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Animal Health Update

🕔11/18/2020 8:52:00 AM 905

Anatara Lifesciences (ASX:ANR) is pleased to provide an update on challenge trials of select Anatara animal health assets.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) $1.4m Raised Through the Completed SPP

🕔11/16/2020 2:26:07 PM 899

Anatara Lifesciences (ASX:ANR) is pleased to advise that the Share Purchase Plan (SPP) announced to the market on 21 October 2020 closed on 11 November 2020 oversubscribed.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Investor Presentation

🕔10/29/2020 9:03:26 AM 1096

Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr. Steven Lydeamore, will present today at AusBiotech +Invest 2020.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Quarterly Financial Report

🕔10/28/2020 9:35:19 AM 1242

Anatara Lifesciences (ASX:ANR) is pleased to release its Appendix 4C for the quarter ending 30th September 2020. The Company's cash plus term deposits at the end of the quarter stood at $1.59m (30th June 2020: $2.7m). On 30th September 2020, the Company had cash at bank of $1.09m and $0.5m in term deposits.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Annual Report to Shareholders

🕔10/27/2020 11:28:37 AM 1073

Anatara Lifesciences Ltd (ASX:ANR) is developing an OTC medicine to address factors associated with gastrointestinal (GI) disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): microbiome dysbiosis, inflammation and mucosal damage.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) CEO Steve Lydeamore to Present at AusBiotech 2020

🕔10/9/2020 3:19:26 PM 1519

Anatara's CEO, Steve Lydeamore will be presenting to investors at AusBiotech + Invest 2020 on 29th October 2020. Register to attend free for qualified investors.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Investor Presentation

🕔9/8/2020 8:28:54 AM 2088

Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr. Steven Lydeamore, will present today at the ASX Small and Mid-Cap Conference 2020, a virtual conference.

Read Full Article

Anatara Lifesciences (ASX:ANR) ASX Small and Mid-Cap Conference 2020

🕔9/1/2020 11:33:08 AM 1588

Steven Lydeamore, Chief Executive Officer, Anatara Lifesciences (ASX:ANR) will be presenting at the ASX Small and Mid-Cap Conference 2020.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Financial Report 30 June 2020

🕔8/24/2020 3:08:51 PM 1113

Anatara Lifesciences (ASX:ANR) today released its Appendix 4E and review of operations for the period ending 30 June 2020.

Read Full Article
###

60,349 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 419) (Last 30 Days: 1335) (Since Published: 60349) 

Company Data

    Headquarters
  • Level 3, 62 Lygon Street
    Carlton South, VIC, 3053
    Australia
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.anataralifesciences.com
  • E:
  • info@anataralifesciences.com

Company Reports